ECSP982530A - NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL - PROTEIN TRANSFERASA - Google Patents
NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL - PROTEIN TRANSFERASAInfo
- Publication number
- ECSP982530A ECSP982530A ECSP982530A ECSP982530A EC SP982530 A ECSP982530 A EC SP982530A EC SP982530 A ECSP982530 A EC SP982530A EC SP982530 A ECSP982530 A EC SP982530A
- Authority
- EC
- Ecuador
- Prior art keywords
- novel sulfonamide
- protein
- transferasa
- farnesil
- sulfonamide inhibitors
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 229950008696 farnesil Drugs 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 230000002159 abnormal effect Effects 0.000 abstract 2
- 230000011712 cell development Effects 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- -1 sulfonamide compounds Chemical class 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describen novedosos compuestos de sulfonamida y composiciones farmacéuticas que son inhibidores de la enzina proteína transferasa. También se describe un método para inhibir la función Ras y, por lo tanto, para inhibir el desarrollo anormal de las células. El método consiste en administrar el novedoso compuesto de sulfonamida a un sistema biológico. Específicamente, el método inhibe el desarrollo anormal de las células en mamíferos tales como seres humanos.Novel sulfonamide compounds and pharmaceutical compositions that are inhibitors of the protein transferase enzyme are described. Also described is a method of inhibiting Ras function and, therefore, of inhibiting abnormal cell development. The method is to administer the novel sulfonamide compound to a biological system. Specifically, the method inhibits abnormal cell development in mammals such as humans.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982530 ECSP982530A (en) | 1998-06-15 | 1998-06-15 | NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL - PROTEIN TRANSFERASA |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982530 ECSP982530A (en) | 1998-06-15 | 1998-06-15 | NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL - PROTEIN TRANSFERASA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982530A true ECSP982530A (en) | 1999-04-13 |
Family
ID=42043450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982530 ECSP982530A (en) | 1998-06-15 | 1998-06-15 | NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL - PROTEIN TRANSFERASA |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982530A (en) |
-
1998
- 1998-06-15 EC ECSP982530 patent/ECSP982530A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU49101A (en) | Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | |
| PY0117895A (en) | IMIDAZOLE DERIVATIVES | |
| BRPI0111222B8 (en) | phosphonate derivatives of glycopeptide. | |
| BRPI0408165A (en) | processes to improve the activity of lignocellulose degradation enzymes | |
| BRPI0509172A (en) | at least one chemical entity, pharmaceutical composition, methods for treating a patient, inhibiting at least one enzyme using atp, and treating at least one disease, use of at least one chemical entity, and method for the manufacture of a medicament | |
| ES2155601T3 (en) | BENZOLACTAMA COMPOUNDS SUBSTITUTED AS AN SUBGONIST OF THE SUBSTANCE P. | |
| MX9207449A (en) | INHIBITORS OF THE PROTEOLYTIC ENZYME DERIVED FROM SACARINE. | |
| ES2111710T3 (en) | PROTEASES THAT INHIBIT AND DETACH BIOFILM. | |
| Fenton et al. | Biogenesis of the mitochondrial enzyme methylmalonyl-CoA mutase. Synthesis and processing of a precursor in a cell-free system and in cultured cells. | |
| ES2094702B1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CANCER DISEASES AND PROCEDURE FOR THEIR PREPARATION. | |
| ES2089687T3 (en) | 4-PHENYL-PIRIDONES AND 4-PHENYL-2-ALCOXIPIRIDINAS SUBSTITUTED AS INHIBITORS OF HMG-COA-REDUCTASA. | |
| CO5050328A1 (en) | SOLVENT SYSTEM FOR THE BEST PENETRATION OF PHARMACEUTICAL COMPOUNDS | |
| BR0317284A (en) | Mitogen-Activated Protein Kinase-2 Aminocyanopyridine Inhibitors | |
| Hope et al. | Secretory phospholipase A2 inhibitors and calmodulin antagonists as inhibitors of cytosolic phospholipase A2 | |
| AR012989A1 (en) | NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL-PROTEIN TRANSFERASE. | |
| ECSP982530A (en) | NOVEL SULFONAMIDE INHIBITORS FROM FARNESIL - PROTEIN TRANSFERASA | |
| ES2054904T3 (en) | PROCEDURE FOR THE PREPARATION OF PEPTIDES WITH ACTIVITY INHIBITOR OF ENZYMATIC SYSTEMS. | |
| Maharana et al. | Depolarization induces acetylation of histone H2B in the hippocampus | |
| ATE299140T1 (en) | FARNESYL PROTEIN TRANSFERASE INHIBITORS | |
| ECSP982531A (en) | NOVEL INHIBITORS OF UREA - N - SUBSTITUTED FOR PROTEIN TRANSFERASE, FARNESILO (CASE IN0728) | |
| GT199900078A (en) | 2-AMINOPYRIDINES CONTAINING SUBSTITUTES FOR CONDENSED RINGS. | |
| ES2190581T3 (en) | 2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ACTIVE IN THE PREVENTION AND TREATMENT OF SEPTIC SHOCK. | |
| AR009013A1 (en) | APPLICATION OF HCG (HUMAN GONADOTROPHINACORIONICA), BETA SUBUNITS, ACTIVE FRAGMENTS AND DERIVED FROM THEM AS INHIBITORS OF METALLOPROTEIN MATRICES AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUCH INHIBITORS | |
| He et al. | L-NMMA and 1400W, inhibitors of iNOS, attenuate the induction of iNOS and NO in primary rabbit costal chondrocytes by fluoride | |
| ECSP972208A (en) | NEW TRICYCLIC CYANOIMINS AND USEFUL AS PROTEIN TRANSFERASE INHIBITORS FARNESILO |